MANGOCEUTICALS, INC. Contracts & Agreements
69 Contracts & Agreements
- Business Finance (30 contracts)
- Business Operations (8)
- Human Resources (22)
- Uncategorized (9)
- Consulting Agreement dated November 11, 2024, and effective October 1, 2024, by and between Mangoceuticals, Inc. and Eugene M. Johnston (Filed With SEC on November 12, 2024)
- $150,000 Promissory Note issued by Mangoceuticals, Inc. in favor of Cohen Enterprises, Inc (Filed With SEC on October 22, 2024)
- Master Distribution Agreement dated July 2, 2024 and entered into on July 9, 2024, by and between Mangoceuticals, Inc. and ISFLST, Inc. (ISFLST) (Filed With SEC on July 11, 2024)
- Omnibus Amendment Agreement No. 1 dated June 27, 2024, entered into between Mangoceuticals, Inc. and Platinum Point Capital LLC (Filed With SEC on July 2, 2024)
- Common Share Purchase Warrant dated June 28, 2024 (1,000,000 shares), granted to Platinum Point Capital LLC (Filed With SEC on July 2, 2024)
- Common Share Purchase Warrant dated June 28, 2024 (500,000 shares), granted to Platinum Point Capital LLC (Filed With SEC on July 2, 2024)
- Patent Purchase Agreement dated April 24, 2024, by and between Mangoceuticals, Inc., as purchaser and Intramont Technologies, Inc., as seller (Filed With SEC on April 25, 2024)
- Registration Rights Agreement (ELOC), dated April 4, 2024, entered into between Mangoceuticals, Inc. and Platinum Point Capital LLC (Filed With SEC on April 11, 2024)
- Common Share Purchase Warrant dated April 4, 2024 (3,300,000 shares), granted to Platinum Point Capital LLC (Filed With SEC on April 11, 2024)
- Securities Purchase Agreement dated April 4, 2024, entered into between Mangoceuticals, Inc. and Platinum Point Capital LLC (Filed With SEC on April 11, 2024)
- Equity Purchase Agreement dated April 4, 2024, entered into between Mangoceuticals, Inc. and Platinum Point Capital LLC (Filed With SEC on April 11, 2024)
- Registration Rights Agreement (SPA), dated April 4, 2024, entered into between Mangoceuticals, Inc. and Platinum Point Capital LLC (Filed With SEC on April 11, 2024)
- Description of the Registrants Securities (Filed With SEC on April 1, 2024)
- Amended and Restated Mangoceuticals, Inc. 2022 Equity Incentive Plan (Filed With SEC on March 26, 2024)
- First Amendment to the Mangoceuticals, Inc. 2022 Equity Incentive Plan (Filed With SEC on March 26, 2024)
- Common Stock Purchase Warrant issued by Mangoceuticals, Inc. to Boustead Securities, LLC on January 22, 2024 (Filed With SEC on January 23, 2024)
- Mangoceuticals, Inc. 2022 Equity Incentive Plan Stock Option Agreement dated December 28, 2023 Jacob Cohen 1,250,000 shares (Filed With SEC on January 2, 2024)
- Common Stock Purchase Warrant issued by Mangoceuticals, Inc. to Boustead Securities, LLC on December 19, 2023 (Filed With SEC on December 19, 2023)
- Underwriting Agreement, dated December 15, 2023, between Mangoceuticals, Inc. and Boustead Securities, LLC (Filed With SEC on December 19, 2023)
- Notice of Restricted Stock Grant and Restricted Stock Grant Agreement dated November 1, 2023 between Mangoceuticals, Inc. and Dr. Douglas Christianson (Filed With SEC on December 11, 2023)
- Advisor Agreement dated November 1, 2023, between Mangoceuticals, Inc. and Dr. Douglas Christianson (Filed With SEC on December 11, 2023)
- Form of Representatives Warrant (Filed With SEC on December 11, 2023)
- Form of Underwriting Agreement (Filed With SEC on December 11, 2023)
- Marketing Agreement dated December 10, 2023, by and between Mangoceuticals, Inc. and Marius Pharmaceuticals (Filed With SEC on December 11, 2023)
- Consulting Agreement dated and effective October 3, 2023, by and between Mangoceuticals, Inc. and Eugene M. Johnston (Filed With SEC on October 4, 2023)
- First Addendum to Master Services Agreement dated September 15, 2023, by and between Mangoceuticals, Inc. and Epiq Scripts, LLC (Filed With SEC on September 21, 2023)
- Consulting Agreement dated September 15, 2023, by and between Mangoceuticals, Inc. and Epiq Scripts, LLC (Filed With SEC on September 21, 2023)
- Service Agreement dated September 1, 2023, by and between Mangoceuticals, Inc. and Greentree Financial Group, Inc (Filed With SEC on September 8, 2023)
- Common Stock Purchase Warrant granted to Boustead Securities, LLC evidencing the right to acquire 87,500 shares of common stock (dated March 23, 2023) (Filed With SEC on May 10, 2023)
- Stock Option Agreement dated May 1, 2023 between Mangoceuticals, Inc. and Amanda Hammer (150,000 option shares) (Filed With SEC on May 4, 2023)
- Employment Agreement dated and effective May 1, 2023, by and between Mangoceuticals, Inc. and Amanda Hammer (Filed With SEC on May 4, 2023)
- Secured Installment Promissory Note dated November 18, 2022, between Mangoceuticals, Inc. and BPI Equipment, Inc (Filed With SEC on February 21, 2023)
- Consulting Agreement dated January 24, 2023, between Mangoceuticals, Inc. and John Helfrich (Filed With SEC on January 26, 2023)
- Consulting Agreement dated January 24, 2023, between Mangoceuticals, Inc. and Maja Matthews (Filed With SEC on January 26, 2023)
- Consulting Agreement dated January 24, 2023, between Mangoceuticals, Inc. and Justin Baker (Filed With SEC on January 26, 2023)
- Consulting Agreement dated January 24, 2023, between Mangoceuticals, Inc. and Sultan Haroon (Filed With SEC on January 26, 2023)
- Service Agreement dated September 22, 2022, by and between Mangoceuticals, Inc. and Greentree Financial Group, Inc (Filed With SEC on January 13, 2023)
- Form of Representatives Warrant (Filed With SEC on January 13, 2023)
- Consulting Agreement dated September 15, 2022, between Mangoceuticals, Inc. and Hsiaoching Chou (Filed With SEC on January 13, 2023)
- Consulting Agreement dated September 15, 2022, between Mangoceuticals, Inc. and David Sandler (Filed With SEC on January 13, 2023)
- Consulting Agreement dated September 6, 2022, between Mangoceuticals, Inc. and Ezekiel Elliott (Filed With SEC on January 13, 2023)
- Consulting Agreement dated September 6, 2022, between Mangoceuticals, Inc. and PHX Global, LLC (Filed With SEC on January 13, 2023)
- Stock Option Agreement dated August 31, 2022 between Mangoceuticals, Inc. and Jonathan Arango (500,000 option shares) (Filed With SEC on January 13, 2023)
- Stock Option Agreement dated August 31, 2022 between Mangoceuticals, Inc. and Jacob D. Cohen (750,000 option shares) (Filed With SEC on January 13, 2023)
- Mangoceuticals, Inc. 2022 Equity Incentive Plan (Filed With SEC on January 13, 2023)
- Executive Employment Agreement dated August 31, 2022, between Mangoceuticals, Inc. and Jonathan Arango (Filed With SEC on January 13, 2023)
- Executive Employment Agreement dated August 31, 2022, between Mangoceuticals, Inc. and Jacob D. Cohen (Filed With SEC on January 13, 2023)
- Master Services Agreement and Statement of Work dated September 1, 2022, and effective August 31, 2022, between Epiq Scripts, LLC and Mangoceuticals, Inc (Filed With SEC on January 13, 2023)
- Physician Services Agreement dated August 1, 2022, between Mangoceuticals, Inc. and BrighterMD, LLC dba Doctegrity (Filed With SEC on January 13, 2023)
- Form of Subscription Agreement (2022 Private Placement) (Filed With SEC on January 13, 2023)
- Stock Purchase Agreement between American International Holdings Corp. and Cohen Enterprises, Inc., dated June 16, 2022 (Filed With SEC on January 13, 2023)
- Form of Common Stock Purchase Warrant (Investors 2022 Private Placement) (Filed With SEC on January 13, 2023)
- Form of Underwriting Agreement (Filed With SEC on January 13, 2023)
- Offer Letter dated October 1, 2022 entered into between Mangoceuticals, Inc. and Eugene M. Johnston (Filed With SEC on January 13, 2023)
- Notice of Restricted Stock Grant and Restricted Stock Grant Agreement dated October 1, 2022 between Mangoceuticals, Inc. and Eugene M. Johnston (Filed With SEC on January 13, 2023)
- Notice of Restricted Stock Grant and Restricted Stock Grant Agreement dated October 14, 2022 between Mangoceuticals, Inc. and Dr. Kenny Myers (Filed With SEC on January 13, 2023)
- October 14, 2022 Offer Letter entered into between Mangoceuticals, Inc. and Dr. Kenny Myers (Filed With SEC on January 13, 2023)
- Notice of Restricted Stock Grant and Restricted Stock Grant Agreement dated October 14, 2022 between Mangoceuticals, Inc. and Alex P. Hamilton (Filed With SEC on January 13, 2023)
- October 14, 2022 Offer Letter entered into between Mangoceuticals, Inc. and Alex P. Hamilton (Filed With SEC on January 13, 2023)
- Notice of Restricted Stock Grant and Restricted Stock Grant Agreement dated October 14, 2022 between Mangoceuticals, Inc. and Lorraine DAlessio (Filed With SEC on January 13, 2023)
- October 14, 2022 Offer Letter entered into between Mangoceuticals, Inc. and Dr. Lorraine DAlessio (Filed With SEC on January 13, 2023)
- Consulting Agreement dated November 1, 2022, between Mangoceuticals, Inc. and White Unicorn, LLC (Filed With SEC on January 13, 2023)
- Master Services Agreement dated December 1, 2022, between Mangoceuticals, Inc. and Global Career Networks, Inc (Filed With SEC on January 13, 2023)
- Consulting Agreement dated December 21, 2022, between Mangoceuticals, Inc. and Chartered Services, LLC (Filed With SEC on January 13, 2023)
- Waiver Agreement dated December 30, 2022, between Mangoceuticals, Inc. and Boustead Securities, LLC (Filed With SEC on January 13, 2023)
- Consulting Agreement dated January 3, 2023, between Mangoceuticals, Inc. and DojoLabs Group, Inc (Filed With SEC on January 13, 2023)
- Advisor Agreement dated January 6, 2023, between Mangoceuticals, Inc. and Dr. Brian Rudman (Filed With SEC on January 13, 2023)
- Advisor Agreement dated January 6, 2023, between Mangoceuticals, Inc. and Jarrett Boon (Filed With SEC on January 13, 2023)
- Consulting Agreement dated January 6, 2023, between Mangoceuticals, Inc. and Bethor, Ltd (Filed With SEC on January 13, 2023)
